Selective mitomycin C and cyclophosphamide induction of apoptosis in differentiating B lymphocytes compared to T lymphocytes in vivo

Immunopharmacology

Volumn 35, Issue 1, 1996, Pages 71-82

  Hemendinger, Richelle A ^a   Bloom, Stephen E ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

apoptosis; B and T lymphocytes; cyclophosphamide; mitomycin C

Indexed keywords

CYCLOPHOSPHAMIDE; MITOMYCIN C;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BURSA FABRICII; CELL CYCLE; CELL DIFFERENTIATION; CELL SPECIFICITY; CELL VIABILITY; CHICK EMBRYO; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS LINKING; DRUG MECHANISM; DRUG SELECTIVITY; EMBRYO; LYMPHOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOCYTE;

EID: 0030273212     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(96)00124-5     Document Type: Article

References (46)

1. Barlogie, B. and Drewinko, B., 1980. Lethal and cytokinetic effects of mitomycin C on cultured human colon cancer cells. Cancer Res. 40: 1973-1980.
2. Barry, M.A., Behhke C.A. and Eastman, A., 1990. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 40: 2353-2362.
3. Bloom. S.E., 1978. Chick embryos for detecting environmental mutagens. In: eds. A. Hollaender and F.J. de Serres, Chemical Mutagens, Vol. 5, Plenum Press, New York, pp. 203-232.
4. Chen, C.H., Chanh, T.C. and Cooper M.D., 1984. Chicken thymocyte-specific antigen identified by monoclonal antibodies: ontogeny, tissue distribution and biochemical characterization. Eur. J. Immunol. 14: 385-391.
5. Cohen, J.J., 1993. Apoptosis. Immunol. Today 14: 126-130.
6. Collins, C., Mortimer, J. and Livingston, R.B., 1989. High-dose cyclophosphamide in the treatment of refractory lymphomas and solid tumor malignancies. Cancer 63: 228-232.
7. Cotter, T.G., Glynn, J.M., Echeverri, F. and Green, D.R., 1992. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Res. 12: 773-780.
8. Damon, R.A., Jr and Harvey, W.R., 1987. Experimental Design, ANOVA and Regression. Harper and Row, New York.
9. Dorr, R.T., Liddil, J.D., Trent, J.M. and Dalson, W.S., 1987. Mitomycin C resistant leukemia cells: association with pleiotropic drug resistance. Biochem. Pharmacol. 36: 3115-3120.
10. Dorr, R.T. and Liddil, J.D., 1991. Modulation of mitomycin C-induced multidrug resistance in vitro. Cancer Chemother. Pharmacol. 27: 290-294.
11. Draetta, G., 1990. Cell cycle control in eukaryotes: molecular mechanisms of cdc2 activation. Trends Biochem. Sci. 15: 378-382.
12. Duvall, E. and Wyllie, A.H., 1986. Death and the cell. Immunol. Today 7: 115-119.
13. Eguchi, Y., Ewert, D.L. and Tsujimoto, Y., 1992. Isolation and characterization of the chicken bcl-2 gene: expression in a variety of tissues including lymphoid and neural organs in adult and embryo. Nucl. Acids Res. 20: 4187-4192.
14. El Azzouzi, B., Tsangaris, G.Th., Pellegrini, O., Manuel, Y., Beneviste J. and Thomas, Y., 1994, Cadium induces apoptosis in a human T cell line. Toxicology 88: 127-129.
15. Gallo, R.C., Whang-Peng, J. and Adamson, R.H., 1971. Studies on the antitumor activity, mechanism of action, and cell cycle effects of camptothecin. J. Natl. Cancer Inst. 46: 789-795.
16. Glick, B., La Via M.F. and Roger, B., 1985. Flow cytometric analysis of bursal, thymic, and splenic cells from normal and cyclophosphamide-treated embryos. Poultry Sci. 64: 723-731.
17. Godfrey, T.E. and Wilbur, D.W., 1972. Clinical experience with mitomycin C in large infrequent doses. Cancer 29: 1647-1652.
18. Hamilton, J.W. and Bloom, S.E., 1986. Correlation between induction of xenobiotic metabolism and DNA damage from chemical carcinogens in the chick embryo in vivo. Carcinogenesis 7: 1101-1106.
19. Hardin, J.A., Hinoshita, F. and Sherr, D.H., 1992. Mechanisms by which benzo[α]pyrene, an environmental carcinogen, suppresses B cell lymphopoiesis. Toxicol Appl Pharmacol 117: 155-164.
20. Hemendinger, R.A., Miller, M.M. and Bloom, S.E., 1995. Selective expression of major histocompatibility complex (MHC) antigens and modulation of T-cell differentiation in chickens with increased MHC-chromosome dosage. Vet. Immunol. Immunopathol. 46: 303-316.
21. Hemendinger, R.A., Putnam, J.R. and Bloom, S.E., 1992. MHC dosage effects on primary immune organ development in the chicken. Dev. Comp. Immunol. 16: 175-186.
22. Herrera, L.A., Tittelbach, H., Gebhart, E. and Ostrosky-Wegman, P., 1991. Changes in the proliferation of human lymphocytes induced by several cytostatics and revealed by the premature chromosome condensation technique. Mut. Res. 263: 101-106.
23. Kerr, J.F.R, Wyllie, A.H. and Currie, A.R., 1972. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer 26: 239-257.
24. Kuehl, B.L., Buchwald, M. and Rauth, A.M., 1993. Characterization of a set of Chinese hamster ovary variant cell lines demonstrating differing sensitivity to mitomycin C. Oncol. Res. 5: 213-221.
25. Kurl, R.N., Abraham, M. and Olnes, M.J., 1993. Early effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCCD) on rat thymocytes in vitro. Toxicology 77: 103-114.
26. Lennon, S.V., Martin, S.J. and Cotter, T.G., 1991. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif. 24: 203-214.
27. Lerman, S.P. and Weidanz, W.P., 1970. The effect of cyclophosphamide on the ontogeny of the humoral immune response in chickens. J. Immunol. 105: 614-619.
28. Misra, R.R. and Bloom, S.E., 1991. Roles of dosage, pharmacokinetics, and cellular sensitivity to damage in the selective toxicity of cyclophosphamide towards B and T cells in development. Toxicology 66: 239-256.
29. Misra, R.R. and Vos, J.-M.H., 1993, Defective replication of psoralen adducts detected at the gene-specific level in xeroderma pigmentosum variant cells. Mol. Cell. Biol. 13: 1002-1012.
30. Misra, R.R., Lorr, N.A. and Bloom, S.E., 1991. Cyclophosphamide metabolism in the primary immune organs of the chick: assays of drug activation, P450 expression, and aldehyde dehydrogenase. Arch. Toxicol. 65: 32-38.
31. Morimoto, K., Sato-Minzuno, M. and Koizumi, A., 1985. Sister-chromatid exchanges and cell-cycle kinetics in human lymphocyte cultures exposed to alkylating mutagens: apparent deformity in dose-response relationships. Mut. Res. 152: 187-196.
32. 2 stage of the cell cycle. Mut. Res. 110: 343-350.
33. Paramithiotis, E. and Ratcliffe, M.J.H., 1993. Bursa-dependent subpopulations of peripheral B lymphocytes in chicken blood. Eur. J. Immunol. 23: 96-102.
34. Pollack, A. and Ciancio, G., 1990. Cell cycle phase-specific analysis of cell viability using Hoechst 33342 and propidium iodide after ethanol preservation. Meth. Cell Biol.: Flow Cytometry 33: 19-24.
35. Potchinsky, M.B., Muscarella, D.E., Hemendinger, R.A. and Bloom, S.E., 1995. Differential sensitivity of B-lineage lymphocytes compared to T-lineage lymphocytes to mitomycin C-induced DNA damage involving cell cycle inhibition and apoptosis. In Vitro Toxicol. in press.
36. Raffray, M. and Cohen, G.M., 1993. Thymocyte apoptosis as a mechanism for tributyltin-induced thymic atrophy in vivo. Arch. Toxicol. 67: 231-236.
37. Raffray, M., McCarthy, D., Snowden, R.T. and Cohen, G.M., 1993. Apoptosis as a mechanism of tributyltin cytotoxicity to thymocytes: relationship of apoptotic markers to biochemical and cellular effects. Toxicol. Appl. Pharmacol. 119: 122-130.
38. Ratcliffe, M.J.H., 1989. Generation of immunoglobulin heavy chain diversity subsequent to cell surface immunoglobulin expression in the avian bursa of Fabricius. J. Exp. Med. 170: 1165-1173.
39. Searle, J., Lawson, T.A., Abbott, P.J., Harmon, B. and Kerr, J.F.R., 1975. An electron-microscope study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells. J. Pathol. 116: 129-138.
40. Smith, P.C. and Sladek, N.E., 1985. Sensitivity of murine B-and T-lymphocytes to oxazaphosphorine and nonoxazaphosphorine nitrogen mustards. Biochem. Pharmacol. 34: 3459-3463.
41. Snedecor, G.W. and Cochran, W.G., Statistical Methods, 7th Ed., The Iowa State Press, Iowa, 1980.
42. cdc2/cyclin B. Cancer Res. 52: 1823-1829.
43. Verweij, J. and Pinedo, H.M., 1990. Mitomycin C: mechanism of action, usefulness and limitations. Anticancer Drugs 1: 5-13.
44. Wilmer, J.L., Erexson, G.L. and Kligerman, A.D., 1984. Sister chromatid exchange induction in mouse B and T lymphocytes exposed to cyclophosphamide in vitro and in vivo. Cancer Res. 44: 880-884.
45. Wilmer, J.L., Colvin, O.M. and Bloom, S.E., 1992. Cytogenetic mechanisms in the selective toxicity of cyclophosphamide analogs and metabolites towards avian embryonic B lymphocytes in vivo. Mut. Res. 268: 115-130.
46. Xu, B.H., Gupta, V. and Singh, S.V., 1994. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance. Arch. Biochem. Biophys. 308: 164-170.